[ADVANCES IN REGENERATIVE MEDICINE FOR THE BRAIN].
Neural stem cells are characterized by their capacity for self-renewal and for differentiation into neural and glial lineages. In addition, multiple studies have identified their therapeutic properties, by which stem cells inhibit local injurious inflammatory processes, protect their microenvironment from injury, and promote repair processes. These unique properties provide the main rationale for current clinical translation of cell therapy in neurodegenerative and neuro-inflammatory diseases. Candidate cell platforms (such as Mesenchymal stem cells, neural and glial stem cells, placental cells) differ in their tissue of origin and differentiation potential, in their use as an autologous or allogeneic graft, in their capacity for expansion and in ethical issues concerning their production. Future use of human embryonic stem cell and induced pluripotent stem cell based technologies may achieve direct graft-induced regeneration. Alternatively, drugs that induce the proliferation, migration and differentiation of resident stem and progenitor cells might facilitate the failing natural tissue repair processes.